Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for HUTCHMED (China) (HCM) over the last 10 years, with Q4 2024 value amounting to $29.8 million.

  • HUTCHMED (China)'s Accumulated Expenses fell 3395.71% to $29.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $29.8 million, marking a year-over-year decrease of 3395.71%. This contributed to the annual value of $29.8 million for FY2024, which is 3395.71% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Accumulated Expenses stood at $29.8 million for Q4 2024, which was down 3395.71% from $45.0 million recorded in Q4 2023.
  • In the past 5 years, HUTCHMED (China)'s Accumulated Expenses ranged from a high of $45.0 million in Q4 2023 and a low of $22.0 million during Q4 2020
  • Moreover, its 5-year median value for Accumulated Expenses was $41.8 million (2021), whereas its average is $36.2 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 9009.19% in 2021, then plummeted by 3395.71% in 2024.
  • Over the past 5 years, HUTCHMED (China)'s Accumulated Expenses (Quarter) stood at $22.0 million in 2020, then soared by 90.09% to $41.8 million in 2021, then rose by 1.57% to $42.4 million in 2022, then grew by 6.14% to $45.0 million in 2023, then crashed by 33.96% to $29.8 million in 2024.
  • Its Accumulated Expenses was $29.8 million in Q4 2024, compared to $45.0 million in Q4 2023 and $42.4 million in Q4 2022.